Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma.
about
Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas.Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma.The nucleotide sugar UDP-glucose mobilizes long-term repopulating primitive hematopoietic cells.Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors.Advances in stem cell mobilization.Intermediate dose etoposide plus G-CSF 16 g/kg is more effective than cyclophosphamide 4 g/m(2) plus G-CSF 10 g/kg in PBSC mobilization of lymphoma patients.Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis.High-dose chemotherapy and auto-SCT in elderly patients with Hodgkin's lymphoma.Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma.Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma.
P2860
Q33389752-D56985F4-AD2B-49D9-95BD-73DB283120B3Q34095620-178C57D4-DA25-4F75-9344-523C9707E06EQ37052874-8DF0DC9C-9A4F-40B6-BA57-044ECB175006Q37963986-6469B08D-02BD-4226-881F-C0167033FA7FQ38183225-A177231B-4B1E-478B-8EC9-E1F9F1223167Q40437476-05665D5B-F5DE-47B5-AE40-05C0E2401E88Q46469277-A7756290-C872-4286-AD13-C541BE4B63FFQ46925369-BE4C39B8-5A9E-475F-A118-BD73193D8ED0Q47582616-9661F175-7F60-4384-A497-E6EC69386D33Q47593598-07C1224E-C1BB-41B9-9448-10DB4BD7B084Q47913355-3566D5DA-1D2C-41CE-BE76-75816D2589A8
P2860
Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Cyclophosphamide, etoposide an ...... ion in patients with lymphoma.
@en
Cyclophosphamide, etoposide an ...... ion in patients with lymphoma.
@nl
type
label
Cyclophosphamide, etoposide an ...... ion in patients with lymphoma.
@en
Cyclophosphamide, etoposide an ...... ion in patients with lymphoma.
@nl
prefLabel
Cyclophosphamide, etoposide an ...... ion in patients with lymphoma.
@en
Cyclophosphamide, etoposide an ...... ion in patients with lymphoma.
@nl
P2093
P2860
P356
P1476
Cyclophosphamide, etoposide an ...... ion in patients with lymphoma.
@en
P2093
Saragosa R
P2860
P2888
P304
P356
10.1038/SJ.BMT.1703653
P407
P577
2002-09-01T00:00:00Z